[Management View]
Village Farms International reported record performance in Q3 2025, with significant growth in EBITDA and margins. Management emphasized disciplined cost structures, strong free cash flow, and liquidity. Key strategic priorities include expanding Canadian and international cannabis production capacity, maintaining EU GMP compliance, and increasing market penetration in The Netherlands. The company also announced a $10 million share repurchase program to enhance shareholder returns.

[Outlook]
The company expects continued growth in revenue and profitability, driven by expanded production capacity in Canada and The Netherlands. Incremental output from the Canadian expansion is expected in Q2 2026, with full ramp-up by early 2027. The Netherlands Phase II facility is projected to increase production fivefold by late Q1 2026. Management remains optimistic about international market opportunities, particularly in Germany and other EU jurisdictions.

[Financial Performance]
- Consolidated net sales: $66.7 million (+21% YoY).
- Net income from continuing operations: $10.8 million ($0.09 per share), up from a net loss of $800,000 in the prior-year period.
- Adjusted EBITDA: $20.7 million (31% of sales), up from $4.7 million (8.5% of sales) YoY.
- Canadian cannabis net sales: $64.1 million (+29% YoY), with international medical exports growing 758%.
- Canadian cannabis gross margin: 56%, up from 26% YoY.
- Cash flow from operations: $24.4 million, up from $6.1 million YoY.

[Q&A Highlights]
**Question 1:** What drove the sequential improvement in cannabis gross margin to 56%, and how sustainable is this level?
**Answer:** Key drivers included improved efficiency, higher crop yields, favorable pricing due to SKU mix, lower packaging costs, and strong international export margins. Management reiterated a long-term gross margin target of 30-40% but aims to exceed this range when possible.

**Question 2:** How has the competitive environment internationally, particularly in Germany, impacted market share gains?
**Answer:** Village Farms has benefited from consistent high-quality production, EU GMP compliance, and direct distribution. Management believes they are the largest exporter of medical cannabis to Europe and expects continued market share gains as international demand grows.

**Question 3:** What is the outlook for The Netherlands, and why did gross margin decline sequentially?
**Answer:** The Netherlands' gross margin decline was attributed to start-up costs and investments in scaling operations. Management targets long-term gross margins of 30-40% and expects significant revenue growth with the Phase II facility coming online in 2026.

**Question 4:** What is the company's strategy for Texas medical cannabis expansion, and how will it impact the Nasdaq listing?
**Answer:** Management is exploring structures to participate in Texas' medical cannabis market without jeopardizing its Nasdaq listing. They are optimistic about the regulatory changes and potential opportunities in Texas.

**Question 5:** How significant is Quebec to the Canadian cannabis business, and what is the impact of regulatory changes?
**Answer:** Quebec is an important market but does not account for 40% of Canadian cannabis revenue. Regulatory changes, such as the introduction of vape products, are expected to drive growth in the legal market.

**Question 6:** What is the competitive landscape for cannabis production in The Netherlands?
**Answer:** Of the 10 licensed producers, eight are operational, with some facing challenges. Village Farms is focused on scaling its Phase II facility, which will increase capacity fivefold, and sees potential opportunities in the competitive landscape.

[Sentiment Analysis]
Analysts expressed a positive tone, commending the company's strong financial performance and strategic execution. Management displayed confidence in their operational capabilities and growth prospects, emphasizing disciplined cost management and market leadership.

[Quarterly Comparison]
| Metric | Q3 2025 | Q3 2024 | YoY Change |
|---------------------------------|-----------------|-----------------|------------|
| Consolidated Net Sales | $66.7M | $55.1M | +21% |
| Net Income from Continuing Ops | $10.8M | -$0.8M | N/A |
| Adjusted EBITDA | $20.7M | $4.7M | +340% |
| Canadian Cannabis Net Sales | $64.1M | $49.7M | +29% |
| Canadian Cannabis Gross Margin | 56% | 26% | +30pp |
| Cash Flow from Operations | $24.4M | $6.1M | +300% |

[Risks and Concerns]
1. Regulatory uncertainties in key markets, including Texas and Quebec.
2. Competitive pressures in The Netherlands and potential challenges in scaling operations.
3. Dependence on international market growth, particularly in Europe.
4. Potential volatility in cannabis pricing and gross margins.

[Final Takeaway]
Village Farms International delivered record-breaking financial performance in Q3 2025, driven by strong execution in Canadian and international cannabis markets. The company is well-positioned for future growth, with strategic capacity expansions in Canada and The Netherlands and a disciplined approach to cost management. While regulatory and competitive risks remain, management's focus on operational excellence and market leadership provides a solid foundation for sustained profitability and shareholder value creation.